Gene Therapy with Autologous, Interleukin 2-Secreting Tumor Cells in Patients with Malignant Melanoma-Reference-Cited by-同舟云学术

Gene Therapy with Autologous, Interleukin 2-Secreting Tumor Cells in Patients with Malignant Melanoma

Published:1999-05-20 Issue:8 Volume:10 Page:1261-1268
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Palmer K.,Moore J.,Everard M.,Harris J.D.,Rodgers S.,Rees R.C.,Murray A.K.,Mascari R.,Kirkwood J.,Riches P.G.,Fisher C.,Thomas J.M.,Harries M.,Johnston S.R.D.,Collins M.K.L.,Gore M.E.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10430349950017941

Reference26 articles.

1. A phase I clinical trial of immunotherapy with interferon-? gene-modified autologous melanoma cells

2. Limited Antitumor T Cell Response in Melanoma Patients Vaccinated with Interleukin-2 Gene-Transduced Allogeneic Melanoma Cells

3. Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases.

4. Biological response modifiers in melanoma

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication;Cancer Gene Therapy;2020-05-18

2. Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis;Journal of Clinical Oncology;2015-03-01

3. Treatment of in-transit melanoma with intra-lesional interleukin-2: A systematic review;Journal of Surgical Oncology;2014-07-03

4. Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapy;Biomaterials;2013-11

5. Comparative Antitumor Effect of Preventive versus Therapeutic Vaccines Employing B16 Melanoma Cells Genetically Modified to Express GM-CSF and B7.2 in a Murine Model;Toxins;2012-10-31